First Presbyopia Eye Drop Approved

The pilocarpine agent improves near and intermediate acuity, according to manufacturer Allergan.

TNS Safe Treatment for Ocular Pain

Study suggests three- to six-month use of a trigeminal neurostimulator decreased eye pain, light and wind sensitivity, and burning sensations.

Stay Alert for Systemic Med Surprises

Many ocular adverse effects may be hiding inside your patient’s pill bottle. Here’s a new way to think about them.

Managing Miotics and Mydriatics

Take a closer look at old, new and future uses of these drugs.

Using Antibiotics in Anterior Segment Care

Bacterial ocular and periocular infections are common in adults and children, but choosing an effective treatment strategy relies on more than an accurate clinical diagnosis.

Dose Escalation

A number of new and exciting pharmaceuticals to help manage ocular disease are on the horizon. Get to know them here.

2021 ARMOR Results Find Staph Resistance Still Problematic

However, S. aureus had a significant decrease in methicillin resistance.

Economic Burden Worsens for Glaucoma Patients

Studies found additional IOP-lowering drops led to higher costs with only short-term benefits and observed a spike in brand name med prices.

Atropine Penetration Minimally Affected by Preservatives

Stability and safety of the drug are better predictors of successful outcomes.

Mississippi Pushes for Expanded Scope of Practice

Proposal includes oral steroids, lid lesion care and laser capsulotomy privileges.